Compounds
US11254689B2 · kind B2 · utility
0Cited by
0References
28Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 15, 2018 |
| Grant date | Feb 22, 2022 |
| Priority date | — |
| Expiry date | Aug 15, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compounds of Formula (I) and their use in therapy, for example in the treatment of mycobacterial infections or in the treatment of diseases caused by mycobacterium, such as tuberculosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.